Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Verlamming
Total 0 results
Nothing found
Sponsors and Collaborators
Foundation for Biosanitary Research and Innovation in Primary Health Care
Plethora Solutions Ltd
United States Department of Defense (DOD)
Paulo Sérgio Gomes Nogueira Borges
Lilly PharmaceuticalCompany
Sudimplant SAS - Groupe TBR
Iyad Naeem Muhammad, PhD
Eurotrials Brasil Consultores Cientificos Ltda
Julian Taylor Green
Arsha Vidya Tirtha
Gunkang Pharmaceuticals, Inc
Foshan Sanshui District People's Hospital
University of Applied Sciences Jena
Korea Otsuka International Asia Arab
Rivierduinen, Centre for Personality disorders Jelgersma
S-Biotek Holding ApS
Oblikue Consulting
904 Hospital of the People's Liberation Army Joint Logistic Support Force
Cardiovascular Center Dedinje, Belgrade, Serbia
Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
View Full List
Medical Conditions
Huntington Chorea
Anemia Acute
Malaria,Falciparum
Brain Tumor, Primary
Testicular Teratoma
Thyroid and Parathyroid Surgery
Visual Attention Span Deficit
Chemotherapy-Induced Neutropenia
Hypothermia Following Anesthesia, Sequela
Serum Albumin Low
Advance Directive Completion
Blepharospasm of Both Eyelids
Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Puberty, Delayed
Deformity Flexion
Post-discharge Pharmacist Counseling to Prevent Readmissions
Vibration; Exposure
Gray Platelet Syndrome
Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
Immunologically-induced Lung Disease
View Full List
Drug Interventions
Celecoxib
ABY-035 i.v.
Cyanoacrylate
Acalabrutinib in combination with VR
F520
Bimatoprost 0.03% eye drops
Mineralocorticoid receptor antagonist
MMV390048 120mg
Furmonertinib 160 mg
Pegfilgrastim
Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
Cytisine
Rovalpituzumab tesirine
Standard medical therapy
Pemetrexed
Sorafenib
Ebselen
S-Adenosyl-Methionine
Vosaroxin
Oxycodone
View Full List
CROs by country
Contract Research Organizations in Armenia
Contract Research Organizations in Belarus
Contract Research Organizations in Congo
Contract Research Organizations in Ecuador
Contract Research Organizations in Ghana
Contract Research Organizations in Guinea
Contract Research Organizations in Lithuania
Contract Research Organizations in Macedonia
Contract Research Organizations in Madagascar
Contract Research Organizations in Peru
Contract Research Organizations in Sweden
Contract Research Organizations in Tanzania
Contract Research Organizations in Ukraine
CRO list by country
CROs in Equatorial Guinea
SGS
All CROs in Equatorial Guinea
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe